What to Expect at the Vaccine World Asia Congress 2025 South East Asia
Attendees
Join over 350 professionals at the 7th Vaccine World Asia Congress 2025 – South East Asia! This is your chance to connect with key industry players, expand your network, and engage in high-level discussions that will shape the future of vaccines.
Companies
Meet 80 leading companies driving innovation in the vaccines sector. Whether you're looking for new partners or exploring the latest breakthroughs, this is the perfect platform to discover what’s next in the industry.
Speakers
Gain exclusive insights from 30 expert speakers who are shaping the future of vaccines. Learn from the best in the field as they share cutting-edge knowledge, practical solutions, and emerging trends you can’t afford to miss.
Concept: SEA'S ONLY VACCINE CONFERENCE FROM DISCOVERY TO DELIVERY
Building on the success of its 6th edition, the 7th Vaccine World Asia Congress 2025 – South- East Asia, emerges as the premier event for vaccine companies in the region. With the rising demand for vaccines to tackle diseases like dengue, hepatitis, and influenza, governments across Southeast Asia are prioritizing immunisation, driving significant investments in vaccine research, development, and distribution. Technological innovations, including mRNA vaccines and enhanced delivery systems, are revolutionizing the market, enabling more rapid and effective responses to health threats.
However, challenges such as logistical barriers, vaccine hesitancy, and economic disparities persist, especially in remote regions with limited healthcare infrastructure. Cold chain logistics and regulatory hurdles continue to hinder the efficient distribution of vaccines across the region.
7th Vaccine World Asia Congress 2025 – South East Asia stands as the go-to event for SEA vaccine companies, providing a platform to explore critical opportunities for growth. Key focuses will include expanding immunisation coverage in underserved areas, advancing universal vaccines, strengthening local manufacturing capabilities, accelerating research, improving manufacturing processes, and integrating innovative technologies to reshape vaccine development throughout Southeast Asia.
What's New in 2025?
Over 95% of C-Level speakers from leading SEA biopharma, pharma & government regulators will be presenting at the conference.
Capable of engaging with ministries from the key countries such as Thailand, Cambodia, Malaysia and the FDA across the Southeast Asian region.
Participate in 7 roundtable discussions covering the latest challenges faced by companies in Southeast Asia from partnership & financing, safety manufacturing to market access led by SEA biopharma thought leaders.
Discover SEA's modern, leading-edge technologies in vaccine R&D, latest manufacturing hurdles, mRNA platform enhancements, managing supply demand and last mile delivery.
Network with 200+ decision-makers from the leading 100 vaccine companies and esteemed government regulatory bodies, including the US FDA and key regulators across South East Asia and APAC.
Top vaccine solution providers, including Tofflon Group, Unifin, Almac Group, Jet8, Dou Yee Enterprises and more will be exhibiting and showcasing the latest technologies at the event.
Facilitate working group discussions with industry professionals in this powerful, interactive format.
100% of the audience will be coming from SEA from the job title of CEOs, CSOs, CTOs, VPs, Executive Director and Heads of Departments from: Manufacturing, Operations, Technical Operations, Process Development, R&D, Clinical Trials, Logistics & Supply Chain Management.
80+ emerging and leading SEA biopharma from Manufacturing, Operations, Technical Operations, Process Development, R&D, Clinical Trials, Logistics & Supply Chain Management have been invited to the conference.
WHO
C-Level Executives: CEOs, CSOs, CTOs; VPs, Executive Director and Heads of Departments for: Manufacturing, Operations,Technical Operations, Process Development, R&D, Clinical Trials, Logistics & Supply Chain Management.
WHAT
South East Asia vaccine market is swiftly emerging as a key player in the global vaccine industry, bolstered by rising investments, technological progress, and strong governmental backing, driven by the region's significant population density and diverse healthcare needs, which generate substantial demand for vaccines.
WHY
To leverage partnership opportunities, learn about the latest technological advancements and spearhead scientific innovation.
Contact
Lara Santiago, Conference Producer
[email protected] | +63 9176 210686
Charmaine Poh, Business Development Manager
[email protected] | +65 6983 6133
Priyanka Lao, Business Development Manager
[email protected] | +65 8143 6248
Share With Your Network
